Page 313 - ACCCN's Critical Care Nursing

290 P R I N C I P L E S A N D P R A C T I C E O F C R I T I C A L C A R E

89. Miller JM, Zipes DP. Management of the patient with cardiac arrhythmias. studies. Antiarrhythmics vs Implantable Defibrillator Study, Cardiac Arrest
In: Braunwald E, Zipes DP, Libby P, eds. Heart disease: a textbook of cardiovas- Study Hamburg, Canadian Implantable Defibrillator Study. Eur Heart J 2000;
cular medicine, 6th edn. Philadelphia: WB Saunders; 2001. 21: 2071–8.
90. Deakin C, Nolan J, Sunde, K, Koster R. European Resuscitation Council 99. Moss AJ, Hall WJ, Cannom DS et al. for the Multicentre Automatic Defibril-
Guidelines for Resuscitation 2010 Section 3. Electrical therapies: Automated lator Implantation Trial Investigators. Improved survival with an implanted
external defibrillators, defibrillation, cardioversion and pacing. Resuscitation defibrillator in patients with coronary artery disease at high risk for ventricu-
2010; 81: 1293–304. lar arrhythmias. New Engl J Med 1996; 335(26): 1933–40.
91. Valenzuela TD, Bjerke HS, Clark LL et al. Rapid defibrillation by nontradi- 100. Mark DB, Nelson CL, Anstrom KJ et al: Cost-effectiveness of ICD therapy in
tional responders: the Casino Project. Acad Emerg Med 1998; 5: 414–15. the sudden cardiac death in heart failure trial (SCD-HeFT). Circulation 2005;
92. Ambler JJ, Zideman DA, Deakin CD. The effect of topical non-steroidal anti- 111: 1727.
inflammatory cream on the incidence and severity of cutaneous burns fol- 101. Swerdlow MD, Kalyanam Shivkumar MD, Jianxin Zhang MS. Determination
lowing external DC cardioversion. Resuscitation 2005; 65(2): 173–8. of the Upper Limit of Vulnerability Using Implantable Cardioverter Defibril-
93. Pinski SL, Sgarbossa EB, Ching E, Trohman RG. A comparison of 50-J versus lator Electrograms. Circulation 2003; 107:3028–33.
100-J shock for direct current cardioversion of atrial flutter. Am Heart J 1999; 102. Viskin S, Rosso R. The top 10 reasons to avoid defibrillation threshold testing
137: 439–42. during ICD implantation. Heart Rhythm 2008; 5(3): 391–3.
94. Pinski KL, Fahy GJ. Implantable cardioverter defibrillators. Am J Med 1999; 103. Sola CL, Bostwick JM. Implantable cardioverter-defibrillators, induced
106: 446–58. anxiety, and quality of life. Mayo Clinic Proc 2005; 80(2): 232–7.
95. Antiarrhythmic versus Implantable Defibrillators Investigators. A compari- 104. Brugada J. Is inappropriate therapy a resolved issue with current implantable
son of antiarrhythmic-drug therapy with implantable defibrillators in cardioverter defibrillators? Am J Cardiol 1993; 83: 40D–44D.
patients resuscitated from near-fatal ventricular arrhythmias. New Engl J Med 105. Kruse J, Finkelmeier B. Permanent pacemakers and implantable cardioverter-
1997; 337: 1576–83. defibrillators. In Finkelmeier BA, ed. Cardiothoracic surgical nursing, 2nd edn.
96. Conolly SJ, Gent M, Roberts RS, et al. Canadian Implantable Defibrillator Philadelphia: Lippincott, Williams & Wilkins; 2000.
Study (CIDS): A randomized trial of the implantable cardioverter defibrilla- 106. Morady F. Radio-frequency ablation as treatment for cardiac arrhythmias.
tor against amiodarone. Circulation 2000; 101: 1297–302. New Engl J Med 1999; 340(7): 534–44.
97. Kuck KH, Cappato R, Siebels J et al. Randomized comparison of antiar- 107. Scheinman MM. Patterns of catheter ablation practice in the United States:
rhythmic drug therapy with implantable defibrillators in patients resusci- results of the 1992 NASPE survey. North American Society of Pacing and
tated from cardiac arrest The Cardiac Arrest Study Hamburg (CASH). Electrophysiology. PACE 1994; 17: 873–5.
Circulation 2000; 102:748–54. 108. Joshi S, Wilber DJ. Ablation of idiopathic right ventricular outflow tract
98. Connolly SJ, Hallstrom AP, Cappato R et al. Meta-analysis of the implantable tachycardia: current perspectives. J Cardiovasc Electrophysiol 2005; 16(Suppl1):
cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS S52–8.